A preliminary assessment of legged mobility provided by a lower limb exoskeleton for persons with paraplegia

Ryan J Farris, Hugo A Quintero, Spencer A Murray, Kevin H Ha, Clare Hartigan, Michael Goldfarb, Ryan J Farris, Hugo A Quintero, Spencer A Murray, Kevin H Ha, Clare Hartigan, Michael Goldfarb

Abstract

This paper presents an assessment of a lower limb exoskeleton for providing legged mobility to people with paraplegia. In particular, the paper presents a single-subject case study comparing legged locomotion using the exoskeleton to locomotion using knee-ankle-foot orthoses (KAFOs) on a subject with a T10 motor and sensory complete injury. The assessment utilizes three assessment instruments to characterize legged mobility, which are the timed up-and-go test, the Ten-Meter Walk Test (10 MWT), and the Six-Minute Walk Test (6 MWT), which collectively assess the subject's ability to stand, walk, turn, and sit. The exertion associated with each assessment instrument was assessed using the Physiological Cost Index. Results indicate that the subject was able to perform the respective assessment instruments 25%, 70%, and 80% faster with the exoskeleton relative to the KAFOs for the timed up-and-go test, the 10 MWT, and the 6 MWT, respectively. Measurements of exertion indicate that the exoskeleton requires 1.6, 5.2, and 3.2 times less exertion than the KAFOs for each respective assessment instrument. The results indicate that the enhancement in speed and reduction in exertion are more significant during walking than during gait transitions.

Figures

Fig. 1
Fig. 1
Vanderbilt lower limb exoskeleton.
Fig. 2
Fig. 2
KAFOs used in assessments. Note that the spreader bar attached at the ankles is removed during reciprocal use.
Fig. 3
Fig. 3
Paraplegic subject wearing Vanderbilt exoskeleton (left) and KAFOs (right).
Fig. 4
Fig. 4
Average time from three trials of TUG test and 10 MWT with KAFOs and exoskeleton, respectively. Error bars indicate one standard deviation from the average.
Fig. 5
Fig. 5
Average distance of three trials of 6 MWT with the KAFOs and exoskeleton, respectively. Error bars indicate one standard deviation from the average.
Fig. 6
Fig. 6
Average speed with KAFOs and exoskeleton, respectively. Error bars indicate one standard deviation from the average.
Fig. 7
Fig. 7
Average increase in heart rate for all tests with the KAFOs and exoskeleton, respectively. Error bars indicate one standard deviation from the average.
Fig. 8
Fig. 8
Average PCI for all tests with the KAFOs and exoskeleton, respectively. Error bars indicate one standard deviation from the average.

Source: PubMed

3
Abonnere